Navigating competitive arenas in rare disease
Treatment choice is beneficial for people living with rare diseases (RDs) and competition can drive important economic advantages for payers.
Industries
Life Sciences
We bring clarity to complex challenges.
For more than 25 years, life science companies, law firms, and regulatory agencies around the globe have turned to CRA’s life sciences consultants when they need clarity and solutions to the industry’s most complex issues. Clients value our deep industry knowledge, rigorous analytic techniques, and decades of hands-on experience spanning thousands of successful engagements.
Engagements
- 01Evaluating unintended impacts of the IRA’s Medicare Drug Price Negotiation Program on small and large molecule medicinesA leading pharmaceutical company sought support from CRA Life Sciences experts in analyzing the patient, health system, and innovation implications of the IRA'sView engagement
- 02Developing an evidence-based framework for sustainable NCCP funding and address global disparities in implementation and outcomesA leading pharmaceutical company sought CRA Life Sciences experts to gain a deeper understanding of how governments plan and finance national cancer strategiesView engagement
- 03Mapping and assessing national impacts of JCAs across EuropeCRA Life Science experts were retained by a client to provide support on the impact of the EU HTA regulation and the associated JCAs on national HTA systems.View engagement
Contact a Life Sciences expert.
See all Life Sciences expertsLatest insights
Upcoming events
IP Watchdog: 4th Annual Life Sciences Masters™ 2025
CRA is a proud sponsor of the conference focusing on the intersection of intellectual property and the biopharmaceutical industry, and will explore the law,...
World Orphan Drug Congress EU 2025
CRA is a proud sponsor of the the largest and most established orphan drug & rare disease meeting of its kind across the globe. From cell and gene therapy,...
Recent events
35th Alzheimer Europe Conference (35AEC)
Ryan Lawlor presents the session titled “Prioritising Alzheimer’s Disease in Europe: Next steps for Policy Action.” Tim Wilsdon moderates the panel discussion...
2nd Annual Washington Health Economics Symposium
Annabelle Fowler presents the CRA paper titled “An Analysis of Medicaid CPI Rebates and the Sustainability of U.S. Generic Markets.” Ashutosh Mishra presents...